Early and sustained improvements in patient-reported outcomes with tralokinumab in combination with topical corticosteroids as needed in moderate-to-severe atopic dermatitis

被引:0
作者
Elewski, B. E. [1 ]
Staender, S. [2 ,3 ]
Zirwas, M. [4 ]
Silvestre, J. F. [5 ]
Kalia, S. [6 ,7 ,8 ]
Gutermuth, J. [9 ,10 ]
Mark, T. [11 ]
Tindberg, A. M. [11 ]
Silverberg, J. I. [12 ]
机构
[1] Univ Alabama Birmingham, Birmingham, AL USA
[2] Univ Hosp Munster, Dept Dermatol, Munster, Germany
[3] Univ Hosp Munster, Interdisciplinary Competence Ctr Chron Pruritus K, Munster, Germany
[4] Prob Med Res, Columbus, OH USA
[5] Hosp Gen Univ Alicante, Dermatol Dept, Alicante, Spain
[6] Univ British Columbia, Dept Dermatol & Skin Sci, Vancouver, BC, Canada
[7] Vancouver Coastal Hlth, Vancouver, BC, Canada
[8] BC Childrens Hosp Res Inst, Vancouver, BC, Canada
[9] Univ Ziekenhuis Brussel, Dept Dermatol, Brussels, Belgium
[10] Vrije Univ Brussel, Brussels, Belgium
[11] LEO Pharma AS, Ballerup, Denmark
[12] George Washington Univ, Sch Med & Hlth Sci, Depat Dermatol, Washington, DC 20052 USA
关键词
D O I
暂无
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
385
引用
收藏
页码:E83 / E84
页数:2
相关论文
共 50 条
[41]   Dupilumab offers early and sustained improvement in sleep in adolescents with moderate-to-severe atopic dermatitis [J].
Beck, L. A. ;
Simpson, E. L. ;
Hong, H. C. H. ;
Bansal, A. ;
Chen, Z. ;
Mina-Osorio, P. ;
Prescilla, R. ;
Gadkari, A. .
BRITISH JOURNAL OF DERMATOLOGY, 2020, 183 (04) :E95-E95
[42]   Dupilumab Offers Early and Sustained Improvement in Sleep in Adolescents With Moderate-to-Severe Atopic Dermatitis [J].
Simpson, Eric ;
Eckert, Laurent ;
Hong, Chih-Ho ;
Bansal, Ashish ;
Chen, Zhen ;
Prescilla, Randy ;
Gadkari, Abhijit .
JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2020, 18 :23-24
[43]   Predicting success with reduced dosing frequency of tralokinumab in patients with moderate-to-severe atopic dermatitis [J].
Weidinger, Stephan ;
Bewley, Anthony ;
Hong, H. Chih-ho ;
Silvestre, Juan Francisco ;
Peris, Ketty ;
Wollenberg, Andreas ;
Ivens, Ulla ;
Soehoel, Anders ;
Steffensen, Louise Abildgaard ;
Tindberg, Ann-Marie ;
Simpson, Eric L. .
BRITISH JOURNAL OF DERMATOLOGY, 2025, 192 (03) :410-419
[44]   A critical evaluation of suitability of tralokinumab for treatment of moderate-to-severe atopic dermatitis in adolescents and adults [J].
Pezzolo, Elena ;
Sechi, Andrea ;
Tartaglia, Jacopo ;
Naldi, Luigi .
EXPERT REVIEW OF CLINICAL IMMUNOLOGY, 2024, 20 (03) :255-266
[45]   Patient-reported outcomes in atopic dermatitis and psoriasis [J].
Secrest, A. M. ;
Gale, C. M. ;
Gardiner, A. ;
Hess, R. .
JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2019, 139 (05) :S103-S103
[46]   USE OF TOPICAL CORTICOSTEROIDS WITH TRALOKINUMAB IN ADULT PATIENTS WITH MODERATE-TO-SEVERE ATOPIC DERMATITIS: RESULTS FROM THE 32-WEEK, PHASE 3 ECZTRA 3 TRIAL [J].
Silverberg, Jonathan I. ;
Pink, Andrew E. ;
Kurbasic, Azra ;
Olsen, Christina Kurre ;
Weidinger, Stephan .
ACTA DERMATO-VENEREOLOGICA, 2021, 101 :55-55
[47]   Comparative Efficacy and Safety of Tralokinumab and Dupilumab in Moderate-to-Severe Atopic Dermatitis: A Narrative Review [J].
Kim, Yoon-Seob .
JOURNAL OF CLINICAL MEDICINE, 2025, 14 (14)
[48]   A Patient-Reported Historical Disease Course and Flare Frequency in Adults With Moderate-to-Severe Atopic Dermatitis-A Pilot Study [J].
Grinich, Erin E. E. ;
Dizon, Matthew P. P. ;
Topham, Christina ;
Chung, Janice ;
Simpson, Eric L. L. .
DERMATITIS, 2022, 33 (6S) :S146-S147
[49]   Long-term improvements observed in tralokinumab-treated patients with moderate-to-severe atopic dermatitis: an ECZTEND interim analysis [J].
Blauvelt, A. ;
Lacour, J. -P. ;
Toth, D. ;
Laquer, V. ;
Beissert, S. ;
Wollenberg, A. ;
Herranz, P. ;
Pink, A. ;
Peris, K. ;
Fangel, S. ;
Saeki, H. .
BRITISH JOURNAL OF DERMATOLOGY, 2021, 185 (03) :E112-E113
[50]   Achieving a deep response on patient-reported outcomes with upadacitinib in patients with moderate-to-severe atopic dermatitis: results from three phase III trials [J].
Chovatiya, R. ;
Schuttelaar, M. -L. ;
Calimlim, B. ;
Liu, Y. ;
Takemoto, S. ;
Staender, S. .
BRITISH JOURNAL OF DERMATOLOGY, 2022, 186 (04) :E161-E161